CMS does not specify effective date for new changes.
The Centers for Medicare and Medicaid Services (CMS) has published a decision memo for Magnetic Resonance Imaging (MRI). The decision memo, posted on Tuesday by CMS, reviewed the proposed updates to the National Coverage Determination (NCD) 220.2 (C )(1) and 220.2 (B) (3) policy. It is important to note that the decision memo did not identify an effective date for these changes.
An MRI is an imaging techniquethat uses powerful magnets, radio waves, and a computer, according to WebMD. The benefit of this testing is that it does not use a form of radiation, unlike Computer Tomography (CT) or X-rays.
The memo provides revised language which removes the contraindication for MRI for Medicare beneficiaries that have an implanted pacemaker or implanted cardioverter defibrillator. Coverage is expanded to include cardiac resynchronization therapy pacemakers or cardiac resynchronization therapy defibrillator devices. This memo also expands coverage to Medicare beneficiaries who have a Federal Drug Administration (FDA)-approved or non-FDA-labeled pacemaker, implantable cardioverter defibrillator, cardiac resynchronization therapy pacemaker, or cardiac resynchronization therapy defibrillator which meet specific MRI criteria. This memo also removes the Coverage with Evidence Development (CED) requirement.
Initially, MRIs were not covered for Medicare beneficiaries who had a pacemaker or metal clips for vascular aneurysm repairs. In July 2011, the pacemakers with FDA labeling or that met the Coverage with Evidence Development criteria were included in Medicare coverage. The Coverage with Evidence Development is the acknowledgement that the testing is used for data gathering in conjunction with a clinical trial. This requirement of Coverage with Evidence Development has been removed.
A significant number of clinical trial summaries were reviewed to determine that MRIs are appropriate for patients with implanted cardiac devices. (The study citations are provided at the end of the memo.) This decision memo indicates that MRI has been approved for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.
The non-FDA-approved devices must continue to meet this set of criteria:
The thirty-day comment period yielded fourteen public comments which included support from physicians, medical device manufacturers, professional organizations, and medical societies. Clinical trial summaries were reviewed which supported the use of MRI technology with the implanted cardiac devices.
Continue to watch the NCD updates for an effective date of this revised policy. The website for the NCD Index is listed in the Resources.
With little fanfare, last week the Centers for Medicare & Medicaid Services (CMS) announced another Review Choice Demonstration Project. Joining the ongoing Review Choice Demonstration
Last week I wrote about the ongoing issue of Medicare Advantage (MA) denials related to appropriate transfer to a skilled nursing facility (SNF) and the
Please log in to your account to comment on this article.
Dr. Ronald Hirsch provides tried-and-true strategies and insight into outpatient in hospital bed stays including determining the applicable definition, who uses it, and when and how to bill for this circumstance, solidified with concrete case examples and expert insight.
Practical solutions for CDM departments to protect your hospital’s revenue.
This webcast teaches hospitals how to comply with CMS price transparency rules and compare their rates with peer hospitals. It covers creating a compliant machine-readable file, comparing negotiated rates, and improving pricing decisions.
The No Surprises Act (NSA) presents a challenge for hospitals and providers who must provide Good Faith Estimates (GFEs) for all schedulable services for self-pay and uninsured patients. Compliance is necessary, but few hospitals have been able to fully comply with the requirements despite being a year into the NSA. This webcast provides an overview of the NSA/GFE policy, its impact, and a step-by-step process to adhere to the requirements and avoid non-compliance penalties.
This expert-guided webcast will showcase tips for providers to ensure appropriate capture of the work performed for a visit. Comprehensive examples will be given that demonstrate documentation gaps and how to educate providers on the documentation necessary to appropriately assign a level of service. You will gain clarification on answers regarding emergency department and urgent care coding circumstances as well as a review of how/when it is appropriate to code for E&M in radiology and more.
Set yourself up for financial and compliance success with expert guidance that breaks down the impactful changes including MS-DRG methodology, surgical hierarchy updates, and many new technology add-on payments (NTAPs). Identify areas of potential challenge ahead of time and master solutions for all 2024 Proposed IPPS changes.
Do you struggle with selecting and appending the correct modifier for your medical claims? Join our must-attend webinar, “Mastering Modifier Usage: Preventing Denials and Ensuring Compliance” to reduce claim denials and improve your reimbursement rates.
Kay Piper reviews the guidance and updates coders and CDISs on important information in the AHA’s fourth quarter 2023 ICD-10-CM/PCS Quarterly Coding Clinic in an easy to access on-demand webcast.
Copyright © 2023 RACmonitor. Powered by MedLearn Media.
